Laks Pernenkil

Mar 8, 2024 | bioprocessonline.com | Laks Pernenkil |Seahee Kim |Daniel Buckley |Samsung BioLogics

What analytics technologies, tools, and instruments do biopharma developers consider requisite in the buildout of a modern biologics/ATMP, manufacturing facility? How are those tools enabling the analytics and controls that are requisite to continuous manufacturing and advancing the industry toward “biopharma 4.0?” Join Bioprocess Online Live March 27th to find out! Registration is free thanks to the support of Culture Bio.

Jan 24, 2024 | bioprocessonline.com | Laks Pernenkil

By Laks Pernenkil, Deloitte In pharmaceutical manufacturing, managing constraints to keep production flowing is a perpetual and complex challenge. When one limitation or challenge is addressed, another emerges elsewhere in the network for different reasons. Facing issues around regulations, market dynamics, sudden stoppage of pipeline products, or a striking increase in product approvals, how the enterprise reacts and the tactics it uses can yield varying, sometimes suboptimal outcomes.